Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
19.11 USD | -5.68% | -6.53% | -17.90% |
Kurzporträt
Mitarbeiterzahl: 56
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 01.04.17 |
Timothy Rolph
FOU | Founder | 70 | 01.04.17 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01.09.18 |
William White
DFI | Director of Finance/CFO | 51 | 01.04.19 |
Chief Tech/Sci/R&D Officer | - | 01.12.20 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 01.05.22 |
Patrick Lamy
PRN | Corporate Officer/Principal | - | 01.01.23 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 01.10.18 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 01.01.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 01.01.17 |
Jane Henderson
BRD | Director/Board Member | 59 | 23.04.19 |
Mark Iwicki
CHM | Chairman | 57 | 01.11.18 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01.09.18 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 09.06.20 |
Jonathan Young
FOU | Founder | 54 | 01.04.17 |
Judy Chou
BRD | Director/Board Member | 58 | 12.07.21 |
Graham Walmsley
BRD | Director/Board Member | 37 | 01.06.18 |
Yuan Xu
BRD | Director/Board Member | 56 | 22.04.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 68 404 445 | 58 254 289 ( 85,16 %) | 0 | 85,16 % |
Unternehmenskontakt
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-17.90% | 1.4 Mrd. | |
-2.80% | 104 Mrd. | |
+0.99% | 97.42 Mrd. | |
+1.78% | 22.2 Mrd. | |
-18.32% | 21.23 Mrd. | |
-10.88% | 18.33 Mrd. | |
-42.33% | 16.35 Mrd. | |
-17.80% | 15.06 Mrd. | |
+5.37% | 13.98 Mrd. | |
+27.57% | 11.66 Mrd. |
- Börse
- Aktien
- A2PLNP Aktie
- Unternehmen Akero Therapeutics, Inc.